Bone-Targeted 2,6,9-Trisubstituted purines: novel inhibitors of Src tyrosine kinase for the treatment of bone diseases

This publication has 23 references indexed in Scilit:

• Src kinase contributes to the metastatic spread of carcinoma cells
  Oncogene, 2002
• v-SRC'S hold over actin and cell adhesions
  Nature Reviews Molecular Cell Biology, 2002
• Src inhibitors: drugs for the treatment of osteoporosis, cancer or both?
  Trends in Pharmacological Sciences, 2000
• Tyrosine kinase Src inhibitors: Potential therapeutic applications
  Drug News & Perspectives, 2000
• TRANCE, a TNF Family Member, Activates Akt/PKB through a Signaling Complex Involving TRAF6 and c-Src
  Molecular Cell, 1999
• c-Src, Receptor Tyrosine Kinases, and Human Cancer
  Advances in Cancer Research, 1999
• Expression of Src Family Kinases and Their Putative Substrates in the Human Preosteoclastic Cell Line FLG 29.1
  Journal of Bone and Mineral Research, 1998
• CELLULAR FUNCTIONS REGULATED BY SRC FAMILY KINASES
  Annual Review of Cell and Developmental Biology, 1997
• Substrate Recognition by Osteoclast Precursors Induces C-src/Microtubule Association
  The Journal of cell biology, 1997
• c-Cbl is downstream of c-Src in a signalling pathway necessary for bone resorption
  Nature, 1996